Advances in Immunomodulatory Mechanisms of Mesenchymal Stem Cells-Derived Exosome on Immune Cells in Scar Formation
Wen Zhao,Huimin Zhang,Rui Liu,Rongtao Cui
DOI: https://doi.org/10.2147/ijn.s412717
IF: 7.033
2023-07-03
International Journal of Nanomedicine
Abstract:Wen Zhao, 1, 2, &ast Huimin Zhang, 1, 2, &ast Rui Liu, 1, 2 Rongtao Cui 1– 3 1 Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China; 2 Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, People's Republic of China; 3 Department of Burn and Plastic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Rongtao Cui, Department of Burn and Plastic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China, Tel +86 18653170822, Email Pathological scars are the result of over-repair and excessive tissue proliferation of the skin injury. It may cause serious dysfunction, resulting in psychological and physiological burdens on the patients. Currently, mesenchymal stem cells-derived exosomes (MSC-Exo) displayed a promising therapeutic effect on wound repair and scar attenuation. But the regulatory mechanisms are opinions vary. In view of inflammation has long been proven as the initial factor of wound healing and scarring, and the unique immunomodulation mechanism of MSC-Exo, the utilization of MSC-Exo may be promising therapeutic for pathological scars. However, different immune cells function differently during wound repair and scar formation. The immunoregulatory mechanism of MSC-Exo would differ among different immune cells and molecules. Herein, this review gave a comprehensive summary of MSC-Exo immunomodulating different immune cells in wound healing and scar formation to provide basic theoretical references and therapeutic exploration of inflammatory wound healing and pathological scars. Keywords: exosomes, inflammation, immune cells, immunoregulation, scars Pathological scars, including hypertrophic scar (HS) and keloids, are abnormal scars at the trauma or surgical sites of the skin and are characterized by the over-proliferation of fibroblasts, abundant production of extracellular matrix (ECM) and excessive deposition of collagen, which normally cause burdens for the patients both psychologically and physiologically. 1–3 It's always a troublesome problem for clinical doctors due to its unclear pathogenesis and shortage of effective therapies. 4,5 Therefore, exploring the potential pathogenesis and developing possible therapeutics for pathological scars are urgently needed. The process of wound healing experiences 4 stages: hemostasis, inflammation, proliferation and remodeling, which we can see that the inflammation is at the beginning of scar formation. 6 Although the exact pathogenesis of pathological scars remains unclear, the inflammation was proven to largely influence the formation and development of HS and keloids. 7,8 An excessive response of inflammation is deemed to contribute to scar formation and fibrosis. 9 Clinical works also showed that infected wounds always need a longer time to heal and will easily develop into more serious scars in most cases than uninfected wounds. 10 However, there are lots of immune cells and molecules that participate in this process, and the specific mechanism of immunomodulation is not fully understood. For example, the polarity of macrophages plays an important role in the formation of pathological scars, especially M2 macrophages could promote the formation and development of HS and keloids. 11 In addition, mast cells, T lymphocytes, neutrophils, Langerhans cells, and natural killer T (NKT) cells are also essential in the immunoregulatory process of scar formation. 12–16 Subsequently, plenty of immune agents were explored for the treatment of HS and keloids, such as triamcinolone acetonide, tacrolimus, imiquimod, fingolimod, et al 17–20 Hydrogel biomaterials with inherent antimicrobial properties offer an attractive and viable solution to wound bacterial infections, which might address this issue and also attenuate scar formation. 21 Thus, further studying the mechanism of immunomodulation during scar formation would provide theoretical references for other researchers and develop more effective immune therapeutics for pathological scars. Exosomes are one kind of nano-sized extracellular vesicle (EVs) with a diameter of 30–150nm derived from various cells, and serve as mediators for cell-to-cell communication. 22 Two other subpopulations of EVs are microvesicles and apoptotic bodies. Exosomes derived from adipose-derived mesenchymal s -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology